Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic.
about
Longitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methodsIdentification and characterization of an Acinetobacter baumannii biofilm-associated protein.Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumanniiThe population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic poolDo biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumanniiDevelopment of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii.Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.Identifying more epidemic clones during a hospital outbreak of multidrug-resistant Acinetobacter baumanniiDiversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center.Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy.Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing schemeClonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in SpainAcinetobacter baumannii: emergence of a successful pathogenDiversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I.Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care unitsMolecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods.Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing.Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumanniiWhole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of Acinetobacter baumannii in ChinaIn vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.Isolation and Characterization of Acinetobacter baumannii Recovered from Campylobacter Selective Medium.Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii.Quantitative assessment of insertion sequence impact on bacterial genome architecture.The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity.Current molecular methods in epidemiological typing of Acinetobacter baumannii.Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysisMolecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital.In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany.TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii.Deciphering multifactorial resistance phenotypes in Acinetobacter baumannii by genomics and targeted label-free proteomics.Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.
P2860
Q28730624-15217109-E0D2-4FBD-9615-DE865836611EQ33306299-3F47EE7F-D536-489F-AAB4-6A4FFF048235Q33520358-74244EBA-F256-4383-B3BA-E7F13A05F745Q33552298-70C44CB1-712E-4256-8670-7D148328DD5DQ33588614-1E305A7C-4DA2-457C-B46A-52BD16BCE52AQ34042171-20460EC0-9AE7-40DE-87E4-0A99A80FAE2BQ34042310-B16BD9F4-3D3C-4BFE-BACA-14679D1C1DE6Q34073492-4AA668DA-02E2-47EE-A65B-13362EEE3821Q34108557-D470CD69-1A43-4353-872D-CB7D6E83A684Q34429996-CEFEB37F-2C14-46CA-BC54-8F63054FF936Q34487712-FCBEB3E3-75CD-4F83-9C40-BAFDF69102A8Q34541346-BDAA59DC-DC07-4AEF-A2C9-E5A4AEF141F1Q34596599-949A419F-E8A6-42B5-9D7F-E61987195C0EQ34740954-9BC533AA-DD37-4AAA-80C0-D44830652109Q34795807-774A46E2-5A50-4838-B143-4710FCA3399EQ35065744-1A5A71A4-AE86-4B25-A9FC-091CA27A7F2EQ35230346-B4962188-E96A-4142-9014-2F027A5CCEC4Q35534215-24E48E0C-0BFA-486A-8B2F-CD42AE686377Q35609595-5C8D58FE-614C-4A4B-99CE-CB5F9057D92AQ35690410-CC08BC49-AA32-459A-B71C-9D1F61DC9169Q36744796-2433924F-8863-4262-89C9-609E81AD7D48Q36884465-BFD2359C-FB4D-45CC-B93D-56F86B2C7E29Q37220041-23A7B414-8B3A-4910-B9A2-5F70CED90EADQ37410441-BFF88DD0-0FE4-425B-B02C-B83852E87DC0Q37421156-A73E9BFA-0590-4281-860B-9EF541487506Q37544621-F76A93AF-FAC4-445A-8491-B98E1ABFED08Q37624613-8D86035E-EF5F-449C-B47D-E7A122F325DDQ37689696-D311CC99-58D0-4872-8EEA-93994A40F95DQ37950314-20FBDC1C-F5A8-4D16-8542-D7C8A6C4EFF4Q38269147-A78481B3-5CD9-4A55-9910-7772DFEC6CE5Q39900310-62C852A3-AAE1-4E8B-B351-DBB44A6681CDQ40196177-FA52974A-CDD7-4502-B287-AC9ABCEBA1EBQ40241381-4CF5545A-A033-4FC8-9288-B0ABA83637B4Q41571185-00CCEB9A-EF19-4F36-B9F2-F4C62CF37B01Q41764831-D05791BF-40F8-404A-9747-A92D2903255CQ42037228-A3D367E9-8E8A-43E4-9E50-1F0C03EA4492Q45076608-B7FE3516-93E5-4A22-80C8-8EB5F15832DAQ47273518-804AB404-A529-4C82-B238-EAF245625E8BQ49958760-A75DA5EC-4396-4DE0-9AB5-7CE22AEE3EF1
P2860
Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Long-term predominance of two ...... strains in the Czech Republic.
@en
Long-term predominance of two ...... strains in the Czech Republic.
@nl
type
label
Long-term predominance of two ...... strains in the Czech Republic.
@en
Long-term predominance of two ...... strains in the Czech Republic.
@nl
prefLabel
Long-term predominance of two ...... strains in the Czech Republic.
@en
Long-term predominance of two ...... strains in the Czech Republic.
@nl
P356
P1476
Long-term predominance of two ...... strains in the Czech Republic.
@en
P2093
Alexandr Nemec
Tanny J K van der Reijden
P304
P356
10.1099/JMM.0.05445-0
P577
2004-02-01T00:00:00Z